Who makes Tacrolimus, Pancea Biotech Limited?

Tacrolimus, Pancea Biotech Limited is developed by University of Cincinnati.

What development phase is Tacrolimus, Pancea Biotech Limited in?

Tacrolimus, Pancea Biotech Limited is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Tacrolimus, Pancea Biotech Limited

University of Cincinnati · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Tacrolimus, Pancea Biotech Limited
Also known as	Panacea Biotech Limited tacrolimus
Sponsor	University of Cincinnati
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Tacrolimus, Pancea Biotech Limited CI brief — competitive landscape report
Tacrolimus, Pancea Biotech Limited updates RSS · CI watch RSS
University of Cincinnati portfolio CI